Poly Medicure
Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
DitchCarbon Score
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Poly Medicure's score of 21 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Poly Medicure's reported carbon emissions
In 2024, Poly Medicure reported total carbon emissions of approximately 36,820,130 kg CO2e, comprising 2,319,850 kg CO2e from Scope 1 and 33,962,280 kg CO2e from Scope 2 emissions. This represents a decrease from 2023, where emissions were about 33,000,560 kg CO2e, with Scope 1 emissions at 3,114,940 kg CO2e and Scope 2 emissions at 30,230,620 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, achieving a significant reduction in emissions intensity per rupee of turnover, decreasing from 3.1e-09 in 2023 to 2.7e-09 in 2024. However, there are currently no specific reduction targets or climate pledges disclosed, indicating a potential area for future commitment. Overall, Poly Medicure's emissions data reflects ongoing efforts to manage and reduce carbon emissions, aligning with industry standards for sustainability and climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 25,400,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 21,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
